[1] Pui CH, Yang JJ, Bhakta N, et al.Global efforts toward the cure of childhood acute lymphoblasticleukaemia[J]. Lancet Child Adolesc Health, 2018, 2(6): 440-454. [2] Mezei G, Sudan M, Izraeli S, et al.Epidemiology of childhood leukemia in the presence and absence of Down syndrome[J]. Cancer Epidemiol, 2014, 38(5): 479-489. [3] Vasudevan S, Tong Y, Steitz JA.Switching from repression to activation: microRNAs can up-regulate translation[J]. Science, 2007, 318(5858): 1931-1934. [4] Turunen TA, Roberts TC, Laitinen P, et al.Changes in nuclear and cytoplasmic microRNA distribution in response to hypoxic stress[J]. Sci Rep, 2019, 9(1): 10332. [5] Sun C, Huang C, Li S, et al.Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development[J]. Oncotarget, 2016, 7(7): 8341-8359. [6] Hong CC, Chen PS, Chiou J, et al.miR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression[J]. Cancer Res, 2014, 74(21): 6280-6290. [7] Ji S, Zhang B, Kong Y, et al.miR-326 Inhibits Gastric Cancer Cell Growth Through Downregulating NOB1[J]. Oncol Res, 2017, 25(6): 853-861. [8] Moya L, Meijer J, Schubert S, et al.Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis[J]. Int J Mol Sci, 2019, 20(5): 1154. [9] Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(2): 83-103. [10] Pui CH, Evans WE.A 50-year journey to cure childhood acute lymphoblastic leukemia[J]. Semin Hematol, 2013, 50(3): 185-196. [11] Kato M, Manabe A.Treatment and biology of pediatric acute lymphoblastic leukemia[J]. Pediatr Int, 2018, 60(1): 4-12. [12] Li Y, Gao Y, Xu Y, et al.Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer[J]. Growth Factors, 2015, 33(4): 267-274. [13] Correction: miR326 Maturation Is Crucial for VEGF-C-Driven Cortactin Expression and Esophageal Cancer Progression[J]. Cancer Res, 2016, 76(1): 182. [14] Wang S, Lu S, Geng S, et al.Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma[J]. Med Oncol, 2013, 30(1): 373. [15] Aberuyi N, Rahgozar S, Ghodousi ES, et al.Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia[J]. Front Oncol, 2019, 9: 1496. |